News In Brief
This article was originally published in The Rose Sheet
Executive Summary
EC Mulls 2013 Animal Test Ban
You may also be interested in...
EU Panel Confirms Animal-Alternative Tests Will Miss 2013 Deadline
A panel of scientific experts says full replacement of animal tests with non-animal alternatives is not possible by the 2013 deadline set under the Seventh Amendment to the European Cosmetics Directive.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.